サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424032

脂質調整剤市場、シェア、規模、動向、産業分析レポート：製品タイプ別、フェーズ別、地域別、セグメント別予測、2024年～2032年

Lipid Regulators Market Share, Size, Trends, Industry Analysis Report, By Type (Statins, Non-statins); By Product; By Phase; By Region; Segment Forecast, 2024 - 2032

出版日
ページ情報
英文 119 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
脂質調整剤市場、シェア、規模、動向、産業分析レポート：製品タイプ別、フェーズ別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、脂質調整剤の世界市場規模は2032年までに117億5,000万米ドルに達する見込みです。同レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

脂質は、人体内で所定の機能を持つ脂肪化合物です。水（極性溶媒）には溶けず、有機溶媒には溶けることが知られています。体内の脂質濃度が一定でないと、冠動脈疾患、心血管疾患、膵炎などを引き起こす可能性があります。このため、脂質、特にコレステロールとトリグリセリドを調整することができる脂質調整剤の必要性が高まっています。人体内の脂質の生産量を低下させたり、除去したりする可能性があることから、予測可能な将来において医薬品分野での採用が大いに期待されています。例えば、MDPIに掲載された2023年の研究では、薬物療法における脂質低下薬の有効性とリスクの探求に焦点が当てられています。

研究者は、世界中の人々の生活を向上させるという観点から、様々な疾患に対する効率的な治療法を開発するために、潜在的な脂質調節因子を明らかにするために多大な努力を行っています。マクロファージ泡沫細胞の薬剤スクリーニングプロセスに関する2023年の研究では、バーテポルフィンが脂質代謝と炎症の調節因子として同定され、アテローム性動脈硬化症の治療に大きな可能性が示唆されました。これは、アテローム性動脈硬化症の治療に採用できるため、脂質調整剤市場の成長をサポートし、マーケットプレースでの大きな需要を促進します。

脂質調整剤は、脂質異常症の治療において、主に血中のコレステロール値の上昇を抑制することで著名です。コレステロール値の上昇はアテローム性動脈硬化症を引き起こす主な要因であり、英国では心血管疾患による死亡者数の増加につながっています。このような疾病の増加は、長期的には脂質調整剤市場の成長を支える可能性が高いです。

特定の生物種における脂質調整剤のリアルタイムの働きに焦点を当てた進行中の研究は、マーケットプレースで脂質調整剤の新たな潜在的機会に遭遇しています。2023年に発表された研究では、ヒレ科魚類における脂質調整剤、スタチン、フィブラートの健康への影響についてレビューが行われました。

脂質調整剤市場レポートハイライト

スタチン部門は、コレステロールを低下させる可能性があるため、今後数年間で最も高い成長が見込まれます。

コレステロール分野は、コレステロール値の上昇に伴う健康問題の増加により、最大の市場シェアを占める。

臨床セグメントは、脂質調節に対処する新薬の技術革新の高まりにより、より大きな収益シェアを経験すると予測されます。

アジア太平洋地域は、高齢者人口の存在に起因して、予測期間中に最速の成長を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の脂質調整剤市場に関する洞察

  • 脂質調整剤市場- フェーズスナップショット
  • 脂質調整剤の市場力学
    • 促進要因と機会
      • 脂質レベルの一貫性のなさに関連する健康問題の増大
      • 国民の健康を増進する政府の取り組みの増加
    • 抑制要因と課題
      • 脂質調整剤に対する意識の低下
  • PESTEL分析
  • 脂質調整剤の市場フェーズの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の脂質調整剤市場、製品別

  • 主な調査結果
  • イントロダクション
  • モノグリセロール
  • コレステロール
  • スフィンゴミエリン
  • ジアシルグリセロール
  • グリセロリン脂質

第6章 世界の脂質調整剤市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • スタチン
  • 非スタチン系

第7章 世界の脂質調整剤市場、フェーズ別

  • 主な調査結果
  • イントロダクション
  • 前臨床
  • 臨床

第8章 世界の脂質調整剤市場、地域別

  • 主な調査結果
  • イントロダクション
    • 脂質調整剤市場評価、地域、2019-2032年
  • 脂質調整剤市場-北米
    • 北米：脂質調整剤市場、製品別、2019-2032年
    • 北米：脂質調整剤市場、フェーズ別、2019-2032年
    • 北米：脂質調整剤市場、タイプ別、2019-2032年
    • 脂質調整剤市場-米国
    • 脂質調整剤市場- カナダ
  • 脂質調整剤市場- 欧州
    • 欧州：脂質調整剤市場、製品別、2019-2032年
    • 欧州：脂質調整剤市場、フェーズ別、2019-2032
    • 欧州：脂質調整剤市場、タイプ別、2019～2032年
    • 脂質調整剤市場- 英国
    • 脂質調整剤市場- フランス
    • 脂質調整剤市場- ドイツ
    • 脂質調整剤市場- イタリア
    • 脂質調整剤市場- スペイン
    • 脂質調整剤市場- オランダ
    • 脂質調整剤市場- ロシア
  • 脂質調整剤市場- アジア太平洋
    • アジア太平洋：脂質調整剤市場、製品別、2019-2032年
    • アジア太平洋：脂質調整剤市場、フェーズ別、2019-2032年
    • アジア太平洋：脂質調整剤市場、タイプ別、2019～2032年
    • 脂質調整剤市場- 中国
    • 脂質調整剤市場- インド
    • 脂質調整剤市場- マレーシア
    • 脂質調整剤市場- 日本
    • 脂質調整剤市場- インドネシア
    • 脂質調整剤市場- 韓国
  • 脂質調整剤市場-中東およびアフリカ
    • 中東およびアフリカ：脂質調整剤市場、製品別、2019-2032年
    • 中東およびアフリカ：脂質調整剤市場、フェーズ別、2019-2032年
    • 中東およびアフリカ：脂質調整剤市場、タイプ別、2019～2032年
    • 脂質調整剤市場- サウジアラビア
    • 脂質調整剤市場- アラブ首長国連邦
    • 脂質調整剤市場- イスラエル
    • 脂質調整剤市場- 南アフリカ
  • 脂質調整剤市場-ラテンアメリカ
    • ラテンアメリカ：脂質調整剤市場、製品別、2019-2032年
    • ラテンアメリカ：脂質調整剤市場、フェーズ別、2019-2032
    • ラテンアメリカ：脂質調整剤市場、タイプ別、2019-2032年
    • 脂質調整剤市場- メキシコ
    • 脂質調整剤市場- ブラジル
    • 脂質調整剤市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie Inc
  • Amgen
  • Andrx Corporation
  • AstraZeneca
  • Bristol-Myers Squibb
  • Merck KGaA
  • Novartis
  • Pfizer
  • Teva Pharmaceuticals
図表

List of Tables

  • Table 1 Global Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Global Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 4 Lipid Regulators Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 8 U.S.: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 11 Canada: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 14 Europe: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 17 UK: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 19 UK: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 20 France: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 22 France: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 23 Germany: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 26 Italy: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 29 Spain: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 35 Russia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 41 China: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 43 China: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 44 India: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 46 India: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 50 Japan: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 56 South Korea: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 65 UAE: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 68 Israel: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 71 South Africa: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 74 Latin America: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 77 Mexico: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 80 Brazil: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • Table 83 Argentina: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Lipid Regulators Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Lipid Regulators Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Lipid Regulators Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Phase
  • Figure 11. Global Lipid Regulators Market, by Phase, 2022 & 2032 (USD Billion)
  • Figure 12. Lipid Regulators Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Lipid Regulators Market
目次
Product Code: PM4334

The global lipid regulators market size is expected to reach USD 11.75 billion by 2032, according to a new study by Polaris Market Research. The report "Lipid Regulators Market Share, Size, Trends, Industry Analysis Report, By Type (Statins, Non-statins); By Product; By Phase; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Lipids are fatty compounds with predetermined functions in the human body. They are known to be insoluble in water (polar solvents) and soluble in organic solvents. The inconsistent levels of lipids in the body can lead to coronary artery diseases, cardiovascular diseases, pancreatitis, and more. This is driving the need for lipid regulators, which can regulate lipids, specifically cholesterol and triglycerides. With the potential to lower production or eliminate the lipids in the human body, they are highly anticipated for adoption in the pharmaceutical space in the foreseeable future. For instance, a 2023 study published in MDPI focused on exploring the effectiveness and risks of lipid-lowering drugs in pharmacotherapy.

Researchers are working enormously to reveal the potential lipid regulators to develop efficient treatments for various diseases with a view to enhancing the lives of people around the world. In a 2023 study on the drug screening process of macrophage foam cells, verteporfin was identified as a regulator of lipid metabolism and inflammation and suggested significant potential in treating atherosclerosis. This supports lipid regulator market growth as it can be employed in the treatment of atherosclerosis, facilitating significant demand in the marketplace.

Lipid regulators are prominent in treating dyslipidemias, mainly in controlling increased cholesterol levels in the blood. The increased cholesterol levels are the major factor that causes atherosclerosis, leading to increased levels of deaths due to cardiovascular diseases in the UK. The rising cases of these diseases are likely to support lipid regulator market growth in the long run.

The ongoing studies focusing on the real-time work of lipid regulators in certain species are encountering new potential opportunities for lipid regulators in the marketplace. A study published in 2023 conducted a review of the health effects of lipid regulators, statins, and fibrates among finfish species.

Lipid Regulators Market Report Highlights

Statins segment is anticipated to witness the highest growth in the coming years due to its potential to lower cholesterol.

Cholesterol segment accounted for the largest market share owing to the rising health issues associated with higher cholesterol levels.

Clinical segment is projected to experience a larger revenue share due to the rising innovation of new drugs in dealing with lipid regulation.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the presence of the elderly population.

The global players include AbbVie Inc, Amgen, Andrx Corporation, AstraZeneca, Bristol-Myers Squibb, Merck KGaA, Novartis, Pfizer, and Teva Pharmaceuticals.

Polaris Market Research has segmented the lipid regulators market report based on type, product, phase, and region:

Lipid Regulators, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Statins
  • Non-Statins

Lipid Regulators, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Monoglycerols
  • Cholesterol
  • Sphingomyelin
  • Diacylglycerols
  • Glycerophospholipids

Lipid Regulators, Phase Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pre-clinical
  • Clinical

Lipid Regulators, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lipid Regulators Market Insights

  • 4.1. Lipid Regulators Market - Phase Snapshot
  • 4.2. Lipid Regulators Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing health issues associated with inconsistent levels of lipids
      • 4.2.1.2. Increase in government initiatives to promote health among its population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lower awareness about the lipid regulators
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lipid Regulators Market Phase Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lipid Regulators Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Monoglycerols
    • 5.3.1. Global Lipid Regulators Market, by Monoglycerols, by Region, 2019-2032 (USD Billion)
  • 5.4. Cholesterol
    • 5.4.1. Global Lipid Regulators Market, by Cholesterol, by Region, 2019-2032 (USD Billion)
  • 5.5. Sphingomyelin
    • 5.5.1. Global Lipid Regulators Market, by Sphingomyelin, by Region, 2019-2032 (USD Billion)
  • 5.6. Diacylglycerols
    • 5.6.1. Global Lipid Regulators Market, by Diacylglycerols, by Region, 2019-2032 (USD Billion)
  • 5.7. Glycerophospholipids
    • 5.7.1. Global Lipid Regulators Market, by Glycerophospholipids, by Region, 2019-2032 (USD Billion)

6. Global Lipid Regulators Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Statins
    • 6.3.1. Global Lipid Regulators Market, by Statins, by Region, 2019-2032 (USD Billion)
  • 6.4. Non-Statins
    • 6.4.1. Global Lipid Regulators Market, by Non-Statins, by Region, 2019-2032 (USD Billion)

7. Global Lipid Regulators Market, by Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
  • 7.3. Pre-clinical
    • 7.3.1. Global Lipid Regulators Market, by Pre-clinical, By Region, 2019-2032 (USD Billion)
  • 7.4. Clinical
    • 7.4.1. Global Lipid Regulators Market, by Clinical, By Region, 2019-2032 (USD Billion)

8. Global Lipid Regulators Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lipid Regulators Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Lipid Regulators Market - North America
    • 8.3.1. North America: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
    • 8.3.3. North America: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4. Lipid Regulators Market - U.S.
      • 8.3.4.1. U.S.: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5. Lipid Regulators Market - Canada
      • 8.3.5.1. Canada: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • 8.4. Lipid Regulators Market - Europe
    • 8.4.1. Europe: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4. Lipid Regulators Market - UK
      • 8.4.4.1. UK: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5. Lipid Regulators Market - France
      • 8.4.5.1. France: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6. Lipid Regulators Market - Germany
      • 8.4.6.1. Germany: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7. Lipid Regulators Market - Italy
      • 8.4.7.1. Italy: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8. Lipid Regulators Market - Spain
      • 8.4.8.1. Spain: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9. Lipid Regulators Market - Netherlands
      • 8.4.9.1. Netherlands: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10. Lipid Regulators Market - Russia
      • 8.4.10.1. Russia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • 8.5. Lipid Regulators Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4. Lipid Regulators Market - China
      • 8.5.4.1. China: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5. Lipid Regulators Market - India
      • 8.5.5.1. India: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6. Lipid Regulators Market - Malaysia
      • 8.5.6.1. Malaysia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7. Lipid Regulators Market - Japan
      • 8.5.7.1. Japan: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8. Lipid Regulators Market - Indonesia
      • 8.5.8.1. Indonesia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9. Lipid Regulators Market - South Korea
      • 8.5.9.1. South Korea: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • 8.6. Lipid Regulators Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4. Lipid Regulators Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5. Lipid Regulators Market - UAE
      • 8.6.5.1. UAE: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6. Lipid Regulators Market - Israel
      • 8.6.6.1. Israel: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7. Lipid Regulators Market - South Africa
      • 8.6.7.1. South Africa: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
  • 8.7. Lipid Regulators Market - Latin America
    • 8.7.1. Latin America: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4. Lipid Regulators Market - Mexico
      • 8.7.4.1. Mexico: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5. Lipid Regulators Market - Brazil
      • 8.7.5.1. Brazil: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6. Lipid Regulators Market - Argentina
      • 8.7.6.1. Argentina: Lipid Regulators Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Lipid Regulators Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Lipid Regulators Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amgen
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Andrx Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. AstraZeneca
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bristol-Myers Squibb
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Teva Pharmaceuticals
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development